The latest report by IMARC Group, titled “Dong Quai Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The global dong quai market size reached US$ 1,905.5 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 3,082.67 Million by 2028, exhibiting a growth rate (CAGR) of 8.50% during 2023-2028.
Dong Quai, scientifically known as Angelica sinensis, is a traditional Chinese herb that has been used for centuries in traditional Chinese medicine (TCM) and is also known by various names such as "female ginseng" or "Chinese Angelica." It is highly regarded for its potential health benefits, particularly for women's reproductive health. It is known for its use in alleviating menstrual discomfort and menopausal symptoms. It is believed to help regulate the menstrual cycle, reduce menstrual pain, and relieve symptoms like hot flashes and mood swings during menopause. Additionally, it is often used to support overall female reproductive health. Beyond its gynecological benefits, Dong Quai is also used in TCM for its potential effects on blood circulation and as a general tonic for vitality. It contains various compounds, including ferulic acid and phytoestrogens, which are thought to contribute to its medicinal properties. At present, Dong Quai is gaining immense traction across the globe as a natural remedy for women's health and hormonal balance.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/dong-quai-market/requestsample
Dong Quai Market Trends and Drivers:
The global dong quai market is primarily driven by the growing interest in herbal and traditional medicine and an increasing focus on women's health and wellness. Dong Quai is known for its potential benefits in regulating menstrual cycles and alleviating menopausal symptoms. Additionally, the rising adoption of alternative and holistic healthcare approaches has fueled the popularity of dong quai as a natural remedy, thereby propelling market growth. Moreover, the rapid expansion of the dietary supplement industry and the availability of dong quai in various forms, such as capsules, extracts, and teas, that makes it more accessible to a global consumer base is another major growth-inducing factor. Apart from this, scientific research into the potential therapeutic properties of dong quai, such as its antioxidant and anti-inflammatory effects, has catalyzed market growth. Furthermore, the heightened awareness of traditional Chinese medicine and herbal remedies in Western markets is contributing to market growth.
Report Segmentation:
The report has segmented the market into the following categories:
Form Insights:
- Powder
- Liquid
- Others
Nature Insights:
- Organic
- Conventional
Application Insights:
- Dietary Supplement
- Pharmaceutical
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Bio-Botanica Inc.
- Happy Herb Co.
- MeiHerb Biotech Co. Ltd.
- Monterey Bay Herb Company
- Xian Yuensun Biological Technology Co. Ltd.
Ask Analyst for Sample Report: https://www.imarcgroup.com/request?type=report&id=12696&flag=C
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
Email: [email protected]
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal